Search clinical trials for: bimatoprost eye drops

Total 1996 results

Universitaire Ziekenhuizen KU Leuven

Completed

Optimization of Sampling and Processing of Samples for Molecular Microbial Research on Ocular Surface Samples (EPSO)

Microbiota | Ocular Surface

Belgium
Aston University
TearLab Corporation

Completed

Tear Osmolarity Clinical Utility in Dry Eye Disease

Dry Eye

United Kingdom
Allergan

Completed

A Study of Bimatoprost 0.01% in the Clinical Setting (APPEAL-Taiwan)

Ocular Hypertension | Glaucoma, Primary Open Angle

Taiwan
Allergan

Completed

A Study of LUMIGAN® RC in the Clinical Setting

Ocular Hypertension | Glaucoma, Primary Open Angle

Canada
Zhongshan Ophthalmic Center, Sun Yat-sen University

Recruiting

The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization

Corneal Neovascularization

China
Medical University of Vienna

Withdrawn

Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease

Dry Eye Syndrome

Austria
Maastricht University Medical Center
Annadal stichting

Unknown

Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis (He-ppi)

Hemochromatosis

Netherlands, Belgium
Tarsier Pharma

Completed

A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma

Uveitic Glaucoma | Non-infectious Anterior Uveitis

United States, Germany, France
Dompé Farmaceutici S.p.A

Completed

A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) (Lumos)

Retinitis Pigmentosa

Italy
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Glaucoma

United States, Colombia
Johann Wolfgang Goethe University Hospital

Withdrawn

Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure

Congestive Heart Failure

Germany
Allergan

Completed

Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence

Hypotrichosis

United States
Rabin Medical Center

Completed

Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues

Thyroid Associated Ophthalmopathies

Israel
National University of Malaysia

Unknown

Umbilical Cord Serum Versus Conventional Eyedrops

Dry Eye Syndromes

Malaysia
McMaster University
The Physicians' Services Incorporated Foundation

Completed

Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICU (REVISE)

Stress Ulcer Prophylaxis

Canada, Australia, Saudi Arabia
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients

Ocular Hypertension | Open Angle Glaucoma

France
Salus University

Not yet recruiting

Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma (NTG)

Normal Tension Glaucoma

United States
AbbVie

Enrolling by invitation

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR (Maia)

Ocular Hypertension | Open-Angle Glaucoma

United States, Argentina, Belgium, Brazil, Canada, Colombia, Czechia, Denmark, Egypt, France, Germany, Hong Kong, Italy, Korea, Republic of, New Zealand, Peru, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Thailan... and more
University of California, San Diego

Completed

24-hour IOP-lowering Effect of 0.01% Bimatoprost

Ocular Hypertension | Glaucoma | Intraocular Pressure

United States
Innovative Medical

Completed

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

Glaucoma

United States
Amneal Pharmaceuticals, LLC
CBCC Global Inc.; Amneal EU, Limited

Not yet recruiting

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

Ocular Hypertension | Open-angle Glaucoma

United States
Allergan

Completed

Efficacy of Ketorolac 0.4% in Prostaglandin Suppression

Inflammation

United States
Duke University

Completed

Study of Bimatoprost Gel on Eyelash Growth

Hypotrichosis | Madarosis

United States
Niğde State Hospital

Completed

Comparison of Autologous Serum Versus Preservative Free Artificial Tear

Dry Eye

Turkey
Allergan

Completed

Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

Dry Eye Disease (DED)

United States
Assiut University

Not yet recruiting

Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis

Keratitis
Wills Eye
Allergan

Completed

Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?

Glaucoma

United States
University of Waterloo
Advanced Vision Research

Completed

A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN) (DUNLIN)

Dry Eye Syndromes

Canada
AbbVie

Available

Expanded Access to Bimatoprost (Durysta)

Open-angle Glaucoma
Medical University of Vienna

Completed

Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye Syndrome

Dry Eye Syndromes

Austria
University of Louisville
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and Infants

Gastroesophageal Reflux

United States
Lotung Poh-Ai Hospital

Completed

Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding (PPI)

Peptic Ulcer Hemorrhage

Taiwan
Mahidol University

Unknown

The Effect of "Eye Drop Guide" on the Success Rate of Eye Drops Self-instillation in Glaucoma Patients

Eye Drops Self-instillation

Thailand
Lumenis Be Ltd.

Completed

Safety of Tinted Soft Scleral Eye Shields When IPL is Applied on Eyelids

Meibomian Gland Dysfunction | Dry Eye Disease

United States
Amneal Pharmaceuticals, LLC
CBCC Global Research

Recruiting

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

Ocular Hypertension | Glaucoma, Open-Angle

United States
Mankind Pharma Limited
CBCC Global Research

Completed

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma (Glaucoma)

Glaucoma, Open-Angle

United States
Allergan

Completed

Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Laboratoires Thea

Completed

Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose

Primary Open Angle Glaucoma | Ocular Hypertension

France
Suzan A Rattan
Al-Kindy College of Medicine

Completed

A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery

Endophthalmitis Postoperative
AstraZeneca

Completed

A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies

Advanced Malignancy

China
Chang Gung Memorial Hospital

Unknown

Eye Drops Study for Myopia Control in Schoolchildren

Myopia, Progressive | Atropine Allergy

Taiwan
Portsmouth Hospitals NHS Trust

Completed

Epiretinal Membrane and Cystoid Macular Oedema Post-cataract Surgery (EPIC)

Epiretinal Membrane | Pseudophakic Cystoid Macular Oedema

United Kingdom
Northwestern University
Allergan

Completed

Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure

Intraocular Pressure | Nail Growth Cessation

United States
Shahid Beheshti University of Medical Sciences

Active, not recruiting

Topical Statin Eye Drop in the Management of the Dry Eye

Dry Eye Disease

Iran, Islamic Republic of
ImmunoGen, Inc.

Not yet recruiting

A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

Recurrent Ovarian Cancer | Folate Receptor-Alpha Positive

United States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
Manistee Partners

Unknown

Topical Bimatoprost in the Treatment of Migraine

Migraine Disorders | Headache Disorders

United States
Laboratoires Thea

Completed

Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.

Ocular Hypertension Glaucoma

Bulgaria
Ferozsons Laboratories Ltd.

Unknown

Role of ProTectis on Infant Colic and Its Effect on Infant Crying Time and Maternal Mental Health (PRIC-SMM)

Infantile Colic | Infant Sleeping Habits | Maternal Mental Health.

Pakistan
Innovative Medical

Completed

Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

Glaucoma

United States
Xiaoliang Gan

Unknown

Effects of Preoperative Using of Eye Patches on Prevention of Emergence Agitation After Cataract Surgery

Child | Anesthesia | Agitation

China

3

Subscribe